In this week’s edition of InnovationRx, we look at Town Hall Ventures’ $440 million haul, the CDC’s “Friday night massacre,” Boehringer’s new lung drug, and more.
ByAmy Feldman,
Forbes Staff
andAlex Knapp,
Forbes Staff.
In this week’s edition of InnovationRx, we look at the Khosla Ventures-Cleveland Clinic partnership, Town Hall Ventures’ $440 million haul, the CDC’s “Friday night massacre,” Boehringer’s new pulmonary fibrosis drug, and more. To get it in your inbox, subscribe here.
In this week’s edition of InnovationRx, we look at a high-tech chair that could revolutionize cancer radiation therapy, AI…
In this week’s edition of InnovationRx, we look at the Forbes 30 Under 30 Healthcare list, the coming barriers to getting…
In this week’s edition of InnovationRx, Medline’s blockbuster IPO, Fred Moll’s surgical robotics investments, Forbes' inaugural…
In this week’s edition of InnovationRx, we look at the battle for Metsera, the departure of FDA’s top drug regulator,…
Bristol Myers Squibb and Microsoft's new partnership aimed at accelerating early detection of lung cancer.
New drugs take too long to get to market because of clinical trial bottlenecks. Two cancer doctors built AI-enabled tech to speed…
